Frontlight ResearchEarly access
Coronary artery disease trials in Japan
13 of 17 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleEndocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)
- Where
- Kawasaki, Matsumoto, Shinagawa Ku, Shinjuku-ku, Tsukuba
- Age
- 20 years to 80 years
- People
- 14
- Run by
- Heartseed Inc.
See details and how to joinNCT07347197 - No phaseTaking peoplePrevail Global Study
- Where
- Kamakura, Kitakyushu, Sendai, tabashi City, Yokohama
- Age
- 18 years and over
- People
- 1,205 worldwide
- Run by
- Medtronic Vascular
See details and how to joinNCT06535854 - No phaseTaking peopleAGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
- Where
- Kochi, Mitaka, Sagamihara, Sapporo
- Age
- 18 years and over
- People
- 1,616 worldwide
- Run by
- Boston Scientific Corporation
See details and how to joinNCT06959524 - Phase 2Taking peopleDose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
- Where
- Kamakura, Kasugai, Matsubara, Matsudo
- Age
- 18 years to 80 years
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07830719 · EU 2026-525974-21-00 - No phaseTaking peopleGuideline Oriented Approach To Lipid Lowering In Asia-Pacific
- Where
- Fukuoka, Mitaka, Osaka
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Stephen Nicholls
See details and how to joinNCT05325034 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Hashima-gun, Higashiosaka-shi, Hiroshima, Hokkaido, Ibaraki, Ichinomiya-shi, Inashiki-gun, Kagoshima, Kamakura-shi, Kanazawa, Kitakyushu-shi, Kurume, Kurume-shi, Kusatsu-shi, Kyoto, Maebashi, Matsubara-shi, Nagaoka-Shi, Nagoya, Ogaki-Shi, Ōmihachiman, Oyama-shi, Sakaimachi, Sapporo, Shinjuku-Ku, Takasaki-Shi, Tsukuba, Ube-shi, Urayasu-shi, Yamagata, Yokohama, Yonago-shi
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - No phaseTaking peopleRandomization of Single vs Multiple Arterial Grafts
- Where
- Saitama
- Age
- 18 years to 70 years
- People
- 4,300 worldwide
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT03217006 - No phaseTaking peopleFractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease
- Where
- Tokyo, Tsuchiura
- Age
- 20 years and over
- People
- 960 worldwide
- Run by
- Seung-Jung Park
See details and how to joinNCT05829889 - No phaseTaking peopleDiabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
- Where
- Tsuchiura
- Age
- 20 years and over
- People
- 1,500 worldwide
- Run by
- Duk-Woo Park, MD
See details and how to joinNCT05831085 - Phase 2Taking peopleExploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG
- Where
- Osaka
- Age
- 18 years to 80 years
- People
- 50
- Run by
- Rohto Pharmaceutical Co., Ltd.
See details and how to joinNCT07192211 - No phaseNot yet taking people in JapanComparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- Where
- Bunkyo-ku, Saitama
- Age
- 18 years and over
- People
- 2,300 worldwide
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT04124120 - Phase 4Taking peopleEfficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
- Where
- Kyoto
- Age
- 20 years and over
- People
- 2,890
- Run by
- Takeshi Morimoto
See details and how to joinNCT05347069 - No phaseTaking peopleComparison of Optical Coherence Tomography-derived Minimal Lumen Area, Invasive Fractional Flow Reserve and FFRCT
- Where
- Ageo, Gifu, Nagano, Osaka, Saitama, Sapporo
- Age
- 18 years and over
- People
- 104 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT03820492